HIV 1 News and Research

RSS
Promising new approach to combat HIV

Promising new approach to combat HIV

ProDOL revolutionizes protein quantification in living cells

ProDOL revolutionizes protein quantification in living cells

Reliability of HIV viral load tests for CAB-LA PrEP questioned in new study

Reliability of HIV viral load tests for CAB-LA PrEP questioned in new study

Abacavir linked to increased cardiovascular risk in HIV patients, study finds

Abacavir linked to increased cardiovascular risk in HIV patients, study finds

Long-acting injectable CAB-LA safe for HIV PrEP during pregnancy, study finds

Long-acting injectable CAB-LA safe for HIV PrEP during pregnancy, study finds

PrEPVacc HIV vaccine trial shows no reduction in infections

PrEPVacc HIV vaccine trial shows no reduction in infections

Elite Controllers: Do their genomes hold the key to curing HIV?

Elite Controllers: Do their genomes hold the key to curing HIV?

Llama-derived molecules target hidden strains of HIV

Llama-derived molecules target hidden strains of HIV

Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses

Novel antiviral protein SAMD9L blocks HIV-1 and other lentiviruses

New HIV test targets neglected strains in global cure hunt

New HIV test targets neglected strains in global cure hunt

Innovative HIV vaccine approaches yield potential for broad protection against viral strains

Innovative HIV vaccine approaches yield potential for broad protection against viral strains

Lenacapavir: A breakthrough in long-acting HIV prevention for cisgender women

Lenacapavir: A breakthrough in long-acting HIV prevention for cisgender women

New US headquarters opened by mass photometry pioneers Refeyn

New US headquarters opened by mass photometry pioneers Refeyn

New strategy targets rare B cells for effective HIV vaccine development

New strategy targets rare B cells for effective HIV vaccine development

Engineered immunogens show promise in inducing HIV broadly neutralizing antibodies

Engineered immunogens show promise in inducing HIV broadly neutralizing antibodies

Breakthroughs in germline-targeting HIV vaccine design for broad protection

Breakthroughs in germline-targeting HIV vaccine design for broad protection

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

Study traces the origin and spread of HIV in Indonesia

Study traces the origin and spread of HIV in Indonesia

New SARS-CoV-2 KP.2 variant defies vaccines with higher spread, study warns

New SARS-CoV-2 KP.2 variant defies vaccines with higher spread, study warns

Breast milk's secret weapon against RSV revealed in new study

Breast milk's secret weapon against RSV revealed in new study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.